Trypanosomiasis Differential Diagnoses

1. Rassi A Jr, Rassi A, Marcondes de Rezende J. American trypanosomiasis (chagas disease). Infect Dis Clin North Am. 2012 Jun. 26(2):275-91. [QxMD MEDLINE Link].

2. Lescure FX, Le Loup G, Freilij H, Develoux M, Paris L, Brutus L, et al. Chagas disease: changes in knowledge and management. Lancet Infect Dis. 2010 Aug. 10(8):556-70. [QxMD MEDLINE Link].

3. Verma A, Manchanda S, Kumar N, Sharma A, Goel M, Banerjee PS. Trypanosoma lewisi or T. lewisi-like Infection in a 37-Day-Old Indian Infant. Am J Trop Med Hyg. 2011 Aug. 85(2):221-4. [QxMD MEDLINE Link].

4. Teixeira AR, Hecht MM, Guimaro MC, Sousa AO, Nitz N. Pathogenesis of chagas' disease: parasite persistence and autoimmunity. Clin Microbiol Rev. 2011 Jul. 24(3):592-630. [QxMD MEDLINE Link].

5. Hanford EJ, Zhan FB, Lu Y, et al. Chagas disease in Texas: recognizing the significance and implications of evidence in the literature. Social Sci Med. 2007 Jul. 65(1):60-79. [QxMD MEDLINE Link].

6. Hwang WS, Zhang G, Maslov D, Weirauch C. Infection rates of Triatoma protracta (Uhler) with Trypanosoma cruzi in Southern California and molecular identification of trypanosomes. Am J Trop Med Hyg. 2010 Nov. 83(5):1020-2. [QxMD MEDLINE Link].

7. Dorn PL, Perniciaro L, Yabsley MJ, Roellig DM, Balsamo G, Diaz J. Autochthonous transmission of Trypanosoma cruzi, Louisiana. Emerg Infect Dis. 2007 Apr. 13(4):605-7. [QxMD MEDLINE Link]. [Full Text].

8. Bern C, Kjos S, Yabsley MJ, Montgomery SP. Trypanosoma cruzi and Chagas' Disease in the United States. Clin Microbiol Rev. 2011 Oct. 24(4):655-81. [QxMD MEDLINE Link].

9. Bern C, Montgomery SP. An Estimate of the Burden of Chagas Disease in the United States. Clin Infect Dis. 2009 Jul 29. 49:e52-4. [QxMD MEDLINE Link].

10. Yadon ZE, Schmunis GA. Congenital Chagas disease: estimating the potential risk in the United States. Am J Trop Med Hyg. 2009 Dec. 81(6):927-33. [QxMD MEDLINE Link].

11. Centers for Disease Control and Prevention. Congenital transmission of Chagas disease - Virginia, 2010. MMWR Morb Mortal Wkly Rep. 2012 Jul 6. 61(26):477-9. [QxMD MEDLINE Link].

12. Carter YL, Juliano JJ, Montgomery SP, Qvarnstrom Y. Acute Chagas disease in a returning traveler. Am J Trop Med Hyg. 2012 Dec. 87(6):1038-40. [QxMD MEDLINE Link].

13. Reisenman CE, Lawrence G, Guerenstein PG, Gregory T, Dotson E, Hildebrand JG. Infection of Kissing Bugs with Trypanosoma cruzi, Tucson, Arizona, USA. Emerg Infect Dis. 2010 Mar. 16(3):400-5. [QxMD MEDLINE Link].

14. Reisenman CE, Gregory T, Guerenstein PG, Hildebrand JG. Feeding and Defecation Behavior of Triatoma rubida (Uhler, 1894) (Hemiptera: Reduviidae) under Laboratory Conditions, and Its Potential Role as a Vector of Chagas Disease in Arizona, USA. Am J Trop Med Hyg. 2011 Oct. 85(4):648-56. [QxMD MEDLINE Link].

15. Stevens L, Dorn PL, Hobson J, de la Rua NM, Lucero DE, Klotz JH, et al. Vector blood meals and chagas disease transmission potential, United States. Emerg Infect Dis. 2012 Apr. 18(4):646-9. [QxMD MEDLINE Link].

16. Eggers P, Offutt-Powell TN, Lopez K, Montgomery SP, Lawrence GG. Notes from the field: identification of a Triatoma sanguisuga "kissing bug" - Delaware, 2018. MMWR Morb Mortal Wkly Rep. 2019 Apr 19. 68 (15):359. [QxMD MEDLINE Link]. [Full Text].

17. Salazar-Schettino PM, Perera R, Ruiz-Hernandez AL, Bucio Torres MI, Zamora-Gonzalez C, Cabrera-Bravo M. Chagas disease as a cause of symptomatic chronic myocardopathy in mexican children. Pediatr Infect Dis J. 2009 Nov. 28(11):1011-3. [QxMD MEDLINE Link].

18. Ramos-Ligonio A, Lopez-Monteon A, Guzman-Gomez D, et al. Identification of a hyperendemic area for Trypanosoma cruzi infection in central Veracruz, Mexico. Am J Trop Med Hyg. 2010 Jul. 83(1):164-70. [QxMD MEDLINE Link].

19. del Puerto R, Nishizawa JE, Kikuchi M, et al. Lineage analysis of circulating Trypanosoma cruzi parasites and their association with clinical forms of Chagas disease in Bolivia. PLoS Negl Trop Dis. 2010 May 18. 4(5):e687. [QxMD MEDLINE Link]. [Full Text].

20. Anez N, Crisante G, Rojas A. Update on Chagas disease in Venezuela--a review. Mem Inst Oswaldo Cruz. 2004 Dec. 99(8):781-7. [QxMD MEDLINE Link].

21. Otero S, Sulleiro E, Molina I, Espiau M, Suy A, Martín-Nalda A. Congenital transmission of Trypanosoma cruzi in non-endemic areas: evaluation of a screening program in a tertiary care hospital in Barcelona, Spain. Am J Trop Med Hyg. 2012 Nov. 87(5):832-6. [QxMD MEDLINE Link].

22. Burgos JM, Diez M, Vigliano C, Bisio M, Risso M, Duffy T. Molecular identification of Trypanosoma cruzi discrete typing units in end-stage chronic Chagas heart disease and reactivation after heart transplantation. Clin Infect Dis. 2010 Sep 1. 51(5):485-95. [QxMD MEDLINE Link].

23. Trindade MÂ, Carvalho NB, Belfort EC, Pagliari C, Gakiya E, Sakai-Valente NY. A patient with erythema nodosus leprosum and Chagas cardiopathy: challenges in patient management and review of the literature. Am J Trop Med Hyg. 2011 Jun. 84(6):973-7. [QxMD MEDLINE Link].

24. Cucunubá ZM, Flórez AC, Cárdenas A, Pavía P, Montilla M, Aldana R, et al. Prevalence and risk factors for Chagas disease in pregnant women in Casanare, Colombia. Am J Trop Med Hyg. 2012 Nov. 87(5):837-42. [QxMD MEDLINE Link]. [Full Text].

25. Brutus L, Ernould JC, Postigo J, Romero M, Schneider D, Santalla JA. Influence of pregnancy on Trypanosoma cruzi parasitemia in chronically infected women in a rural Bolivian community. Am J Trop Med Hyg. 2011 May. 84(5):808-12. [QxMD MEDLINE Link]. [Full Text].

26. Cordova E, Maiolo E, Corti M, Orduna T. Neurological manifestations of Chagas' disease. Neurol Res. 2010 Apr. 32(3):238-44. [QxMD MEDLINE Link].

27. Diazgranados CA, Saavedra-Trujillo CH, Mantilla M, Valderrama SL, Alquichire C, Franco-Paredes C. Chagasic encephalitis in HIV patients: common presentation of an evolving epidemiological and clinical association. Lancet Infect Dis. 2009 May. 9(5):324-30. [QxMD MEDLINE Link].

28. Muñoz J, Coll O, Juncosa T, Vergés M, del Pino M, Fumado V. Prevalence and vertical transmission of Trypanosoma cruzi infection among pregnant Latin American women attending 2 maternity clinics in Barcelona, Spain. Clin Infect Dis. 2009 Jun 15. 48(12):1736-40. [QxMD MEDLINE Link].

29. Oliveira I, Torrico F, Munoz J, Gascon J. Congenital transmission of Chagas disease: a clinical approach. Expert Rev Anti Infect Ther. 2010 Aug. 8(8):945-56. [QxMD MEDLINE Link].

30. De Rissio AM, Riarte AR, García MM, Esteva MI, Quaglino M, Ruiz AM. Congenital Trypanosoma cruzi infection. Efficacy of its monitoring in an urban reference health center in a non-endemic area of Argentina. Am J Trop Med Hyg. 2010 May. 82(5):838-45. [QxMD MEDLINE Link].

31. Murcia L, Carrilero B, Munoz-Davila MJ, Thomas MC, López MC, Segovia M. Risk factors and primary prevention of congenital chagas disease in a nonendemic country. Clin Infect Dis. 2013 Feb. 56(4):496-502. [QxMD MEDLINE Link].

32. Kun H, Moore A, Mascola L, Steurer F, Lawrence G, Kubak B. Transmission of Trypanosoma cruzi by heart transplantation. Clin Infect Dis. 2009 Jun 1. 48(11):1534-40. [QxMD MEDLINE Link].

33. Zaniello BA, Kessler DA, Vine KM, Grima KM, Weisenberg SA. Seroprevalence of Chagas infection in the donor population. PLoS Negl Trop Dis. 2012. 6(7):e1771. [QxMD MEDLINE Link]. [Full Text].

34. Brutus L, Castillo H, Bernal C, Salas NA, Schneider D, Santalla JA, et al. Detectable Trypanosoma cruzi parasitemia during pregnancy and delivery as a risk factor for congenital Chagas disease. Am J Trop Med Hyg. 2010 Nov. 83(5):1044-7. [QxMD MEDLINE Link]. [Full Text].

35. Bastos CJ, Aras R, Mota G, et al. Clinical outcomes of thirteen patients with acute chagas disease acquired through oral transmission from two urban outbreaks in northeastern Brazil. PLoS Negl Trop Dis. 2010 Jun 15. 4(6):e711. [QxMD MEDLINE Link]. [Full Text].

36. Miles MA. Orally acquired Chagas disease: lessons from an urban school outbreak. J Infect Dis. 2010 May 1. 201(9):1282-4. [QxMD MEDLINE Link].

37. Alarcón de Noya B, Díaz-Bello Z, Colmenares C, Ruiz-Guevara R, Mauriello L, Zavala-Jaspe R, et al. Large urban outbreak of orally acquired acute Chagas disease at a school in Caracas, Venezuela. J Infect Dis. 2010 May 1. 201(9):1308-15. [QxMD MEDLINE Link].

38. Shikanai-Yasuda MA, Carvalho NB. Oral transmission of chagas disease. Clin Infect Dis. 2012 Mar. 54(6):845-52. [QxMD MEDLINE Link].

39. Rosenblatt JE. Laboratory diagnosis of infections due to blood and tissue parasites. Clin Infect Dis. 2009 Oct 1. 49(7):1103-8. [QxMD MEDLINE Link].

40. Riera C, Verges M, Iniesta L, Fisa R, Gállego M, Tebar S, et al. Identification of a Western Blot Pattern for the Specific Diagnosis of Trypanosoma cruzi Infection in Human Sera. Am J Trop Med Hyg. 2012 Mar. 86(3):412-6. [QxMD MEDLINE Link].

41. Avila HA, Pereira JB, Thiemann O, et al. Detection of Trypanosoma cruzi in blood specimens of chronic chagasic patients by polymerase chain reaction amplification of kinetoplast minicircle DNA: comparison with serology and xenodiagnosis. J Clin Microbiol. Sep 1993. 31(9):2421-6. [QxMD MEDLINE Link]. [Full Text].

42. Avila HA, Sigman DS, Cohen LM, et al. Polymerase chain reaction amplification of Trypanosoma cruzi kinetoplast minicircle DNA isolated from whole blood lysates: diagnosis of chronic Chagas' disease. Mol Biochem Parasitol. Oct 1991. 48(2):211-21. [QxMD MEDLINE Link].

43. Qvarnstrom Y, Schijman AG, Veron V, Aznar C, Steurer F, da Silva AJ. Sensitive and specific detection of Trypanosoma cruzi DNA in clinical specimens using a multi-target real-time PCR approach. PLoS Negl Trop Dis. 2012. 6(7):e1689. [QxMD MEDLINE Link]. [Full Text].

44. Bern C, Verastegui M, Gilman RH, Lafuente C, Galdos-Cardenas G, Calderon M, et al. Congenital Trypanosoma cruzi transmission in Santa Cruz, Bolivia. Clin Infect Dis. 2009 Dec 1. 49(11):1667-74. [QxMD MEDLINE Link].

45. Russomando G, Sanchez Z, Meza G, de Guillen Y. Shed acute-phase antigen protein in an ELISA system for unequivocal diagnosis of congenital Chagas disease. Expert Rev Mol Diagn. 2010 Sep. 10(6):705-7. [QxMD MEDLINE Link].

46. Mallimaci MC, Sosa-Estani S, Russomando G, Sanchez Z, Sijvarger C, Alvarez IM. Early diagnosis of congenital Trypanosoma cruzi infection, using shed acute phase antigen, in Ushuaia, Tierra del Fuego, Argentina. Am J Trop Med Hyg. 2010 Jan. 82(1):55-9. [QxMD MEDLINE Link]. [Full Text].

47. Barbosa MM, P. Nunes Mdo Carmo, Ribeiro AL, et al. N-terminal proBNP levels in patients with Chagas disease: a marker of systolic and dyastolic dysfunction of the left ventricle. Eur J Echocardiography. 2007 Jun. 8(3):204-12. [QxMD MEDLINE Link].

48. Ndao M, Spithill TW, Caffrey R, et al. Identification of novel diagnostic serum biomarkers for Chagas' disease in asymptomatic subjects by mass spectrometric profiling. J Clin Microbiol. 2010 Apr. 48(4):1139-49. [QxMD MEDLINE Link]. [Full Text].

49. Corbucci HA, Haber DM, Bestetti RB, Cordeiro JA, Fioroni ML. QT interval dispersion in patients with chronic heart failure secondary to Chagas' cardiomyopathy: correlation with clinical variables of prognostic significance. Cardiovasc Pathol. 2006 Jan-Feb. 15(1):18-23. [QxMD MEDLINE Link].

50. Acquatella H. Echocardiography in Chagas heart disease. Circulation. 2007 Mar 6. 115(9):1124-31. [QxMD MEDLINE Link].

51. Bowman NM, Kawai V, Gilman RH, et al. Autonomic Dysfunction and Risk Factors Associated with Trypanosoma cruzi Infection among Children in Arequipa, Peru. Am J Trop Med Hyg. 2011 Jan. 84(1):85-90. [QxMD MEDLINE Link]. [Full Text].

52. Altcheh J, Moscatelli G, Moroni S, Garcia-Bournissen F, Freilij H. Adverse Events After the Use of Benznidazole in Infants and Children With Chagas Disease. Pediatrics. 2010 Dec 20. [QxMD MEDLINE Link].

53. Bustamante JM, Lo Presti MS, Rivarola HW, et al. Treatment with benzidazole or thioridazine in the chronic phase of experimental Chagas disease improves cardiopathy. Int J Antimicrob Agents. 2007 Jun. 29(6):733-737. [QxMD MEDLINE Link].

54. de Andrade AL, Zicker F, de Oliveira RM, et al. Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection. Lancet. Nov 23 1996. 348(9039):1407-13. [QxMD MEDLINE Link].

55. Laucella SA, Mazliah DP, Bertocchi G, Alvarez MG, Cooley G, Viotti R. Changes in Trypanosoma cruzi-specific immune responses after treatment: surrogate markers of treatment efficacy. Clin Infect Dis. 2009 Dec 1. 49(11):1675-84. [QxMD MEDLINE Link]. [Full Text].

56. Pinazo MJ, Espinosa G, Gállego M, López-Chejade PL, Urbina JA, Gascón J. Successful treatment with posaconazole of a patient with chronic chagas disease and systemic lupus erythematosus. Am J Trop Med Hyg. 2010 Apr. 82(4):583-7. [QxMD MEDLINE Link]. [Full Text].

57. Bern C, Montgomery SP, Katz L, Caglioti S, Stramer SL. Chagas disease and the US blood supply. Curr Opin Infect Dis. 2008 Oct. 21(5):476-82. [QxMD MEDLINE Link].

58. Mejia AM, Hall BS, Taylor MC, Gómez-Palacio A, Wilkinson SR, Triana-Chávez O. Benznidazole-Resistance in Trypanosoma cruzi Is a Readily Acquired Trait That Can Arise Independently in a Single Population. J Infect Dis. 2012 Jul. 206(2):220-8. [QxMD MEDLINE Link].

59. Le Loup G, Pialoux G, Lescure FX. Update in treatment of Chagas disease. Curr Opin Infect Dis. 2011 Oct. 24(5):428-34. [QxMD MEDLINE Link].

60. Guedes PM, Silva GK, Gutierrez FR, Silva JS. Current status of Chagas disease chemotherapy. Expert Rev Anti Infect Ther. 2011 May. 9(5):609-20. [QxMD MEDLINE Link].

61. Bern C. Antitrypanosomal therapy for chronic Chagas' disease. N Engl J Med. 2011 Jun 30. 364(26):2527-34. [QxMD MEDLINE Link].

62. Murcia L, Carrilero B, Munoz MJ, Iborra MA, Segovia M. Usefulness of PCR for monitoring benznidazole response in patients with chronic Chagas' disease: a prospective study in a non-disease-endemic country. J Antimicrob Chemother. 2010 Aug. 65(8):1759-64. [QxMD MEDLINE Link].

63. Gallerano RH, Marr JJ, Sosa RR. Therapeutic efficacy of allopurinol in patients with chronic Chagas' disease. Am J Trop Med Hyg. 1990 Aug. 43(2):159-66. [QxMD MEDLINE Link].

64. Apt W, Arribada A, Zulantay I, et al. Itraconazole or allopurinol in the treatment of chronic American trypanosomiasis: the result of clinical and parasitological examinations 11 years post-treatment. Ann Trop Med Parasitol. 2005 Dec. 99(8):733-41. [QxMD MEDLINE Link].

65. Lo Presti MS, Rivarola HW, Bustamante JM, et al. Thioridazine treatment prevents cardiomyopathy in Trypanosoma cruzi mice. Int J Antimicrob Agents. 2004 Jun. 23(6):634-636. [QxMD MEDLINE Link].

66. Lee BY, Bacon KM, Connor DL, Willig AM, Bailey RR. The potential economic value of a Trypanosoma cruzi (Chagas disease) vaccine in Latin America. PLoS Negl Trop Dis. 2010 Dec 14. 4(12):e916. [QxMD MEDLINE Link]. [Full Text].

Germaine L Defendi, MD, MS, FAAP Associate Clinical Professor, Department of Pediatrics, Olive View-UCLA Medical Center

Germaine L Defendi, MD, MS, FAAP is a member of the following medical societies: American Academy of Pediatrics

Disclosure: Nothing to disclose.

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Russell W Steele, MD Clinical Professor, Tulane University School of Medicine; Staff Physician, Ochsner Clinic Foundation

Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, Southern Medical Association

Disclosure: Nothing to disclose.

Ashir Kumar, MD, MBBS FAAP, Professor Emeritus, Department of Pediatrics and Human Development, Michigan State University College of Human Medicine

Ashir Kumar, MD, MBBS is a member of the following medical societies: Infectious Diseases Society of America, American Association of Physicians of Indian Origin

Disclosure: Nothing to disclose.

Leslie L Barton, MD Professor Emerita of Pediatrics, University of Arizona College of Medicine

Leslie L Barton, MD is a member of the following medical societies: American Academy of Pediatrics, Association of Pediatric Program Directors, Infectious Diseases Society of America, and Pediatric Infectious Diseases Society

Disclosure: Nothing to disclose.

Antonio Muñiz, MD Professor of Emergency Medicine and Pediatrics, University of Texas Medical School at Houston; Medical Director of the Pediatric Emergency Department, Children's Memorial Hermann Hospital

Antonio Muñiz, MD is a member of the following medical societies: American Academy of Emergency Medicine, American Academy of Pediatrics, American College of Emergency Physicians, American Heart Association, American Medical Association, Society for Academic Emergency Medicine, and Southern Medical Association

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article